Bupropion

"Bupropion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The hydrochloride is available as an aid to smoking cessation treatment.

Descriptor ID	D016642
MeSH Number(s)	D02.522.818.110
Concept/Terms	Bupropion Bupropion Amfebutamone (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone Bupropion Hydrochloride, (+-)-Isomer Bupropion Hydrochloride, (+-)-Isomer Zyntabac Zyntabac Quomen Quomen Wellbutrin Wellbutrin Zyban (Anti-Smoking) Zyban (Anti-Smoking) Bupropion Hydrochloride Bupropion Hydrochloride Bupropion, (+-)-Isomer Bupropion, (+-)-Isomer

Below are MeSH descriptors whose meaning is more general than "Bupropion".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Ketones [D02.522]
Propiophenones [D02.522.818]
Bupropion [D02.522.818.110]

Below are MeSH descriptors whose meaning is related to "Bupropion".

Below are MeSH descriptors whose meaning is more specific than "Bupropion".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bupropion" by people in this website by year, and whether "Bupropion" was a major or minor topic of these publications.

Bar chart showing 37 publications over 19 distinct years, with a maximum of 5 publications in 2007 and 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
2000	1	0	1
2001	1	0	1
2002	2	0	2
2003	2	0	2
2004	2	0	2
2005	0	1	1
2007	3	2	5
2008	3	2	5
2009	1	0	1
2010	3	1	4
2011	1	0	1
2012	2	1	3
2013	0	1	1
2014	0	1	1
2015	1	0	1
2016	2	1	3
2020	1	0	1
2021	1	0	1

Below are the most recent publications written about "Bupropion" by people in Profiles.

Trivedi MH, Walker R, Ling W, Dela Cruz A, Sharma G, Carmody T, Ghitza UE, Wahle A, Kim M, Shores-Wilson K, Sparenborg S, Coffin P, Schmitz J, Wiest K, Bart G, Sonne SC, Wakhlu S, Rush AJ, Nunes EV, Shoptaw S. Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021 01 14; 384(2):140-153.

View in: PubMed
Leone FT, Zhang Y, Evers-Casey S, Evins AE, Eakin MN, Fathi J, Fennig K, Folan P, Galiatsatos P, Gogineni H, Kantrow S, Kathuria H, Lamphere T, Neptune E, Pacheco MC, Pakhale S, Prezant D, Sachs DPL, Toll B, Upson D, Xiao D, Cruz-Lopes L, Fulone I, Murray RL, O'Brien KK, Pavalagantharajah S, Ross S, Zhang Y, Zhu M, Farber HJ. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 07 15; 202(2):e5-e31.

View in: PubMed
Motschman CA, Gass JC, Wray JM, Germeroth LJ, Schlienz NJ, Munoz DA, Moore FE, Rhodes JD, Hawk LW, Tiffany ST. Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline. Drug Alcohol Depend. 2016 Dec 01; 169:180-189.

View in: PubMed
Fujioka K, Plodkowski R, O'Neil PM, Gilder K, Walsh B, Greenway FL. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. Int J Obes (Lond). 2016 09; 40(9):1369-75.

View in: PubMed
Bolen RD, Campbell Z, Bonilha L, Edwards JC. Alpha coma related to intentional bupropion overdose. J Neurol Sci. 2016 Jun 15; 365:48-9.

View in: PubMed
Hawk LW, Ashare RL, Rhodes JD, Oliver JA, Cummings KM, Mahoney MC. Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior? Nicotine Tob Res. 2015 Nov; 17(11):1377-84.

View in: PubMed
Winhusen TM, Brigham GS, Kropp F, Lindblad R, Gardin JG, Penn P, Hodgkins C, Kelly TM, Douaihy A, McCann M, Love LD, DeGravelles E, Bachrach K, Sonne SC, Hiott B, Haynes L, Sharma G, Lewis DF, VanVeldhuisen P, Theobald J, Ghitza U. A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers. J Clin Psychiatry. 2014 Apr; 75(4):336-43.

View in: PubMed
Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e61S-e77S.

View in: PubMed
Wynn WP, Stroman RT, Almgren MM, Clark KJ. The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation. J Pharm Pract. 2012 Dec; 25(6):591-9.

View in: PubMed
Kasza KA, Hyland AJ, Borland R, McNeill AD, Bansal-Travers M, Fix BV, Hammond D, Fong GT, Cummings KM. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2013 Jan; 108(1):193-202.

View in: PubMed

People

Explore

Similar Concepts

Top Journals